Literature DB >> 11239468

NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.

G Xiao1, E W Harhaj, S C Sun.   

Abstract

Processing of the nf(kappa)b2 gene product p100 to generate p52 is an important step in NF-kappaB regulation. We show that this step is negatively regulated by a processing-inhibitory domain (PID) within p100 and positively regulated by the NF-kappaB-inducing kinase (NIK). While the PID suppresses the constitutive processing of p100, NIK induces p100 processing by stimulating site-specific phosphorylation and ubiquitination of this precursor protein. Further, a natural mutation of the gene encoding NIK in alymphoplasia (aly) mice cripples the function of NIK in p100 processing, causing a severe defect in p52 production. These data suggest that NIK is a specific kinase regulating p100 processing and explain why the aly and nf(kappa)b2 knockout mice exhibit similar immune deficiencies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239468     DOI: 10.1016/s1097-2765(01)00187-3

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  350 in total

1.  Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.

Authors:  G Xiao; M E Cvijic; A Fong; E W Harhaj; M T Uhlik; M Waterfield; S C Sun
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

2.  Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype.

Authors:  Hye Sun Kuehn; Julie E Niemela; Karthik Sreedhara; Jennifer L Stoddard; Jennifer Grossman; Christian A Wysocki; M Teresa de la Morena; Mary Garofalo; Jingga Inlora; Michael P Snyder; David B Lewis; Constantine A Stratakis; Thomas A Fleisher; Sergio D Rosenzweig
Journal:  Blood       Date:  2017-08-04       Impact factor: 22.113

3.  Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism.

Authors:  Benjamin Mordmüller; Daniel Krappmann; Meral Esen; Elmar Wegener; Claus Scheidereit
Journal:  EMBO Rep       Date:  2003-01       Impact factor: 8.807

Review 4.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

5.  Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.

Authors:  Shelby O'Connor; Stuart D Shumway; Ian J Amanna; Colleen E Hayes; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

6.  Inhibition of NF-kappaB activity by IkappaBbeta in association with kappaB-Ras.

Authors:  Yi Chen; Sebastien Vallee; Joann Wu; Don Vu; John Sondek; Gourisankar Ghosh
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

7.  NF-kappa B1 p105 regulates T cell homeostasis and prevents chronic inflammation.

Authors:  Mikyoung Chang; Andrew J Lee; Leo Fitzpatrick; Minying Zhang; Shao-Cong Sun
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.

Authors:  You-Sun Kim; Sergei A Nedospasov; Zheng-Gang Liu
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line.

Authors:  Masaya Higuchi; Chikako Tsubata; Rie Kondo; Sakiko Yoshida; Masahiko Takahashi; Masayasu Oie; Yuetsu Tanaka; Renaud Mahieux; Masao Matsuoka; Masahiro Fujii
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

10.  Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation.

Authors:  Nagalakshmi Nadiminty; Wei Lou; Soo Ok Lee; Xin Lin; Donald L Trump; Allen C Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.